Table 4.
Analysis of risk factors affecting mortality in patients with ECOPD.
| Univariable | Multivariable-Model 1 | Multivariable-Model 2 | ||||
|---|---|---|---|---|---|---|
| OR (95%CI) | P | OR (95%CI) | P | OR (95%CI) | P | |
| Age | 1.057 (1.010, 1.107) | 0.017 | 1.050 (1.002, 1.101) | 0.042 | 1.045 (0.994, 1.099) | 0.085 |
| Gender | 0.964 (0.355, 2.617) | 0.943 | ||||
| EOS ≥ 2% | 0.203 (0.047, 0.867) | 0.031 | 0.225 (0.052, 0.971) | 0.046 | 0.336 (0.071, 1.584) | 0.168 |
| White blood cell count | 1.182 (1.094, 1.276) | <0.001 | 1.125 (1.034, 1.225) | 0.006 | ||
| Procalcitonin | 1.008 (0.984, 1.033) | 0.511 | ||||
| NT-proBNP | 1.000 (1.000, 1.000) | <0.001 | 1.000 (1.000, 1.000) | <0.001 | ||
| Hypertension | 0.793 (0.365, 1.723) | 0.559 | ||||
| Diabetes | 1.311 (0.539, 3.186) | 0.550 | ||||
| Heart failure | 2.675 (1.083, 6.610) | 0.033 | 1.82 (0.725, 4.682) | 0.199 | ||
| Coronary heart disease | 1.361 (0.560, 3.310) | 0.497 | ||||